Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Vaccine|September 6, 2002
A novel recombinant vaccine which protects mice against ricin intoxicationJoan E Smallshaw, Ana Firan, John R Fulmer, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 8, 2006
A pilot clinical trial of a recombinant ricin vaccine in normal humansEllen S Vitetta, Joan E Smallshaw, Elaine Coleman, et al.
International Journal of Cancer|September 10, 2005
Effect of an anti-CD54 (ICAM-1) monoclonal antibody (UV3) on the growth of human uveal melanoma cells transplanted heterotopically and orthotopically in SCID miceShixuan Wang, Elaine J Coleman, Laurentiu M Pop, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 12, 2013
TLR-independent neutrophil-derived IFN-γ is important for host resistance to intracellular pathogensCarolyn R Sturge, Alicia Benson, Megan Raetz, et al.
International Immunopharmacology|March 21, 2006
Generation and characterization of a novel tetravalent anti-CD22 antibody with improved antitumor activity and pharmacokineticsXiao-Yun Liu, Laurentiu M Pop, Derry C Roopenian, et al.
Human Vaccines & Immunotherapeutics|January 27, 2016
Recent advances in the development of vaccines against ricinRobert N Brey, Nicholas J Mantis, Seth H Pincus, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2002
Targeting multiple Her-2 epitopes with monoclonal antibodies results in improved antigrowth activity of a human breast cancer cell line in vitro and in vivoCamelia I Spiridon, Maria-Ana Ghetie, Jonathan Uhr, et al.
Nature Biotechnology|March 11, 2003
Genetic engineering of an immunotoxin to eliminate pulmonary vascular leak in miceJoan E Smallshaw, Victor Ghetie, Jose Rizo, et al.
Vaccine|September 6, 2020
Endpoint and epitope-specific antibody responses as correlates of vaccine-mediated protection of mice against ricin toxinGreta Van Slyke, Dylan J Ehrbar, Jennifer Doering, et al.
International Journal of Cancer|June 19, 2009
Specific thermal ablation of tumor cells using single-walled carbon nanotubes targeted by covalently-coupled monoclonal antibodiesRadu Marches, Pavitra Chakravarty, Inga H Musselman, et al.
Pageof 6